Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1Phase 4 1Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma 4Small Cell Lung Carcinoma 2Multiple Myeloma 2Hematologic Neoplasms 2Neutropenia 1Lymphoma, Non-Hodgkin 1Advanced Pancreatic Cancer 1

Interventions

pegylated granulocyte colony-stimulating factor 1ceftolozane, tazobactam drug combination 1Vitamin B 12 1Vancomycin 1Transplantation 1Piperacillin, Tazobactam Drug Combination 1Peripheral Blood Stem Cell Transplantation 1Moxifloxacin 1Loratadine 1Folic Acid 1Daptomycin 1Cloxacillin 1Ciprofloxacin 1Caspofungin 1Amoxicillin-Potassium Clavulanate Combination 1Amikacin 1Algorithms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Neutropenia × pegylated granulocyte colony-stimulating factor × Clear all
NCT04773327 2021-02-26

Efficacy and Safety of PEG-rhG-CSF in the Prevention of Neutropenia After Chemo in Pts With Gynecological Malignancies

Fudan University

Phase NA Unknown
150 enrolled

Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡